Skip to content

A multi-stage clinical study on the prognosis of sepsis with hypocalcemia and the value of calcium intervention

A multi-stage clinical study on the prognosis of sepsis with hypocalcemia and the value of calcium intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067377
Enrollment
Unknown
Registered
2023-01-05
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Control group:10%Glucose solution
Experimental group:Calcium
Risk factors Group:Nothing.
Prognostic group:Nothing.

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The first and second stages: adult sepsis patients admitted to the ICU. Diagnostic criteria for sepsis: According to the Sepsis 3.0 standard, infection + SOFA score >= 2 points; 2. The third stage: Adult patients with sepsis and severe hypocalcemia admitted to the ICU. Diagnostic criteria for sepsis: According to the Sepsis 3.0 standard, infection + SOFA score >= 2 points. Severe hypocalcemia standard: serum ionized calcium level < 1.0 mmol/L.

Exclusion criteria

Exclusion criteria: 1. The first and second stages: those who have one of the following conditions are excluded from this study: the duration of sepsis when admitted to the ICU is > 48 hours; calcium supplementation, albumin, massive blood transfusion or blood purification treatment are given 72 hours before admission to the ICU; pregnant and lying-in women ; acute pancreatitis; history of chronic renal insufficiency; parathyroidectomy; history of thyroid surgery; patients with severe trauma or massive bleeding; 2. The third stage: Those who have one of the following conditions are excluded from this study: the duration of sepsis when entering the ICU is > 48 hours; calcium supplementation, albumin, massive blood transfusion or blood purification treatment are given 72 hours before entering the ICU; pregnant women; acute pancreatitis; history of chronic renal insufficiency; parathyroidectomy; history of thyroid surgery; patients with severe trauma or massive bleeding; patients expected to die within 48 hours.

Design outcomes

Primary

MeasureTime frame
hospital mortaliy;

Secondary

MeasureTime frame
mortaliy of 28d;length of ICU stay;length of ICU stay;Mechanical ventilation time;Time of vasoactive drug use;SOFA of Day 7;Blood transfusion volume;

Countries

China

Contacts

Public ContactLei Huang

Peking University Shenzhen Hospital

hl0248@outlook.com+86 13510331883

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026